Investigation as non-lethal incapacitating agent DMHP and its
O-
acetate ester were extensively investigated by the
US military chemical weapons program in the
Edgewood Arsenal experiments, as possible non-lethal incapacitating agents. DMHP has three
stereocenters and consequently has eight possible
stereoisomers, which differ considerably in potency. The mixture of all eight isomers of the
O-acetyl ester was given the code number EA-2233, with the eight individual isomers numbered EA-2233-1 through EA-2233-8. The most potent isomer is EA-2233-2, with an active dose range in humans of 0.5–2.8 μg/kg (i.e. ~35–200 μg for a 70 kg adult). Active doses varied markedly between individuals, but when the dose of EA-2233 was taken up to 1–2 mg, all volunteers were considered to be incapable of performing military duties, with the effects lasting as long as 2–3 days. DMHP is metabolized in a similar manner to THC, producing the active metabolite 11-hydroxy-DMHP, but the
lipophilicity of DMHP is even higher than that of THC itself, giving it a long duration of action and an extended half-life in the body of between 20 and 39 hours, with the half-life of the 11-hydroxy-DMHP metabolite being longer than 48 hours. DMHP and its esters produce
sedation and mild
hallucinogenic effects similar to large doses of
THC. However, they also cause pronounced
hypotension (low blood pressure), occurring at doses well below the hallucinogenic dose, which can lead to severe
dizziness,
fainting,
ataxia and
muscle weakness, sufficient to make it difficult to stand upright or carry out any kind of vigorous physical activity. The acute toxicity of DMHP was found to be low in both human and animal studies, with the
therapeutic index measured as a ratio of
ED50 to
LD50 in animals being around 2000 times. There have been no recorded deaths caused by any DMHP EA-2233 stereoisomers 1–8, only symptoms that are entirely consistent with the highest-known levels of THC intoxication.
Military application The combination of strong incapacitating effects and a favorable safety margin led the Edgewood Arsenal team to conclude that DMHP and its derivatives, especially the O-acetyl ester of the most active isomer, EA-2233-2, were among the more promising non-lethal incapacitating agents to come out of their research program. However, DMHP had the disadvantage of sometimes producing severe
hypotension at pre-incapacitating doses, which did not occur with the more widely studied and publicized belladonnoid
anticholinergic agents, such as
3-Quinuclidinyl benzilate (BZ), which was discovered and subsequently weaponized. Military applications of synthetic cannabinoids were limited because the drug was both illegal and politically toxic to study via laboratory administration to enlisted servicemen. Both EA-2233-2 and the red-oil THC distillate predecessor, EA-1476, received limited budget and resources compared to the study of other incapacitating agents of BZ derivatives and
LSD, (which was widely believed at the time to be a viable mind-control and
truth serum useful in a variety of Cold War applications). Initially, the 8 stereoisomers of EA-2233 could not be separated; later, two of the individual isomers of EA-2233 were isolated and tested, but were found to cause both
orthostatic hypotension and minimal effects on performance at the very low doses used. EA-2233 did not seem to have sufficient potency to be of military interest, since an oral dose of 60mcg/kg caused a maximum decline of only 40% (at most) in performance at language and number processing tasks. == See also ==